Search results for "dosing"

Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4 clinical trial of Zymfentra...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the Ministry of Food and Drug Safety for...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
More Stem Cells Doesn't Mean Better Results: Why Cell Count Alone Falls Short

More Stem Cells Doesn't Mean Better Results: Why Cell Count Alone Falls Short

Following the box-office success of the film Spider-Man: Brand New Day, public attention has once again turned to...
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines

Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines

Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform,...
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s...
Don't Take All Your Supplements at Once: A Morning-to-Night Guide to Optimal Timing

Don't Take All Your Supplements at Once: A Morning-to-Night Guide to Optimal Timing

Many people take whatever supplements they missed earlier in the day right before bed or wash them down with morning...
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...